Teva reporta resultados positivos de un fármaco para el tratamiento de la piel
La empresa israelí informó en el estudio que los pacientes mostraron mejoras en la pigmentación de la piel con vitiligo
Valoración
Teva's positive vitiligo drug results could open a new therapeutic pathway for a condition with limited treatment options. The improvements in skin pigmentation observed in the study are a meaningful clinical signal, but the durability and safety profile will determine regulatory and commercial potential. Investors will watch for the full data presentation and the company's next steps toward a pivotal trial.